Navigation Links
Bio-Matrix Scientific Group, Inc. Announces Preferred Stock Dividend and Spinoff of Wholly-Owned Subsidiary, Entest Biomedical, Inc.
Date:4/21/2009

SAN DIEGO, April 21 /PRNewswire-FirstCall/ -- Bio-Matrix Scientific Group, Inc. (OTC Bulletin Board: BMSN), a San Diego-based biotechnology research and development company, announced today that its Board of Directors has declared a stock dividend to common and preferred shareholders of record as of May 5th, 2009 to be paid to shareholders on or about May 15th, 2009.

Eligible registered Common shareholders will be entitled to receive one share of Series B Preferred Stock for every 50 shares of Bio-Matrix Scientific Group, Inc. Common Stock owned as of the Record Date. Eligible registered Preferred shareholders will be entitled to receive one share of Series B Preferred Stock for every 50 shares of Bio-Matrix Scientific Group, Inc. Preferred Stock owned as of the Record Date.

Each holder of Series B Preferred Stock shall be entitled to two votes per share on all matters submitted to the stockholders.

The Preferred Share dividends will only be issued in the name of the beneficial owner of the Bio-Matrix Scientific Group Common and Preferred Stock and no dividend shares will be issued in the name of a broker dealer to disseminate to its clients.

Eligible Common shareholders whose Common shares of Bio-Matrix Scientific Group, Inc. are held in a brokerage account ("Street Name") must contact the brokerage firm holding their account to ensure that the dividend is processed correctly. Currently, no Preferred Shares are held in Street Name.

Broker Dealers holding Common shares in Street Name on behalf of clients shall be required to produce lists of Common shareholders designated by such Broker-Dealers as beneficial owners of the Company's Common stock as of the Record Date. Any lists provided by Broker Dealers must reconcile with records on file with the Depository Trust and Clearance Corporation (DTC) before the dividend may be paid by the Company.

Bio-Matrix al
'/>"/>

SOURCE Bio-Matrix Scientific Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NIH News Confirms Trend in Stem Cell Storage Facilities, says CEO of San Diego-based Bio-Matrix Scientific Group
2. Bio-Matrix Scientific Group CEO Tells Wall Street Transcript That Positive Cash Flow Is Possible in 09; New Stem Cell Banking Facility Is Growth Vehicle Over the Next Two Years, Says CEO in Exclusive News Interview
3. Bio-Matrix Scientific Group, Inc. Gets Updated Stock Recommendation By KonLin Investment Letter
4. Bio-Matrix Scientific Group, Inc. Highlighted in LifeSciencesWorld.com Special Report; Stem Cell Market Projected to Exceed $8 Billion Worldwide by 2016
5. Bio-Matrix Scientific Group Featured as Stock Pick in Oakleys Column on WallStreetCorner.com
6. Bio-Matrix Scientific Group Announces New Hires to Management Team
7. E&K Scientific Announces New Accuflow Product Line
8. Boston Scientific Announces First Quarter Special Items
9. Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher
10. Paul Keim Appointed to febits Scientific Advisory Board
11. Amorcyte Reports Phase I Results of AMR-001 to Improve Recovery From Severe Heart Attack at ACC Annual Scientific Session
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ) ... optimized Erk inhibitor molecule for development, thus achieving ... new class of potential cancer therapies. ... for therapeutic intervention in cancer. Recently approved compounds ... B-Raf and Mek inhibitors. Erk inhibitors may be ...
(Date:7/29/2015)... ... 29, 2015 , ... Costello served as Lead Levee Design Engineering Manager for ... County, Texas area from future storm surge flooding, such as occurred in Hurricane Ike ... alignment alternatives for providing protection, Costello also balanced socio-economic and environmental needs ...
(Date:7/28/2015)... July 29, 2015 A ... acquiring, rapidly developing and commercialising innovative medicines to ... Highly experienced management team; blue chip ...   Mereo BioPharma Group Ltd ("Mereo"), a recently-formed ... ( c. £76.5m), gross, from blue chip institutional investors ...
(Date:7/28/2015)... -- People with a common form of hearing loss ... profound improvements in their hearing and understanding of speech ... multicenter study led by specialists at NYU Langone Medical ... of print in the journal The Laryngoscope July 7, researchers ... the United States implanted hybrid cochlear ...
Breaking Biology Technology:Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3Preventing Storm Surge Flooding in Houston 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 5Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 6Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 7Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 8Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 9Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 10Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 11Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 3
... Guam became a living laboratory for scientists as they ... listen for rhinoceros beetles. A grant from USDA IPM ... detection of insects, to travel to Guam to collaborate ... Eradication Project. The results of this research were recently ...
... Scientific publication Lab Manager Magazine has entered into a collaboration with ... able to serve their audiences of laboratory managers in industry, government ... ... Ontario (PRWEB) April 14, 2009 -- Lab Manager Magazine, one of ...
... Okla., April 14 Aaron,s Bridge presents Autism ... 13-14, 2009, at The Embassy Suites Hotel and ... The conference will feature seminars devoted to educating ... MD; Bryan Jepson, MD; Dan Rossignol, MD; and ...
Cached Biology Technology:Lab Manager Magazine and Association of Laboratory Managers (ALMA) Collaborate 2Defeat Autism Now!(R) Regional Conference to be Held in Oklahoma June 13-14, 2009 2
(Date:6/30/2015)... , June 30, 2015 Genisphere ... company as CEO to help further develop Genisphere,s therapeutics ... of partnering experience, having spent much of the last ... Therakine, Amgen, Baxter Bioscience, and Johnson & Johnson. Tom ... on Technology and Biotech Corporate Finance. He graduated from ...
(Date:6/26/2015)... Utah , June 26, 2015 ATL Technology, ... and devices with specialties in single use solutions, headquartered in ... of MedConx, Inc. (a California corporation ... and San Jose, Costa Rica ). ... Costa Rica with ATL Technology,s existing facility ...
(Date:6/25/2015)... LAKE CITY , June 25, 2015  Imagine ... first steps toward a healthier, happier life. That,s exactly ... is designed to do. The cutting-edge, portable health program ... offers real-life solutions to help improve your lifestyle and ... Association awards dinner and gala Wednesday night, USANA,s THA ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
... of the ,neglected tropical diseases, left aside by big pharma ... regions. But then more attention has to be paid to ... the World Health Organization urgently need to be changed. So ... based on ten years of research in Congo. The ...
... of damselfish, Stegastes nigricans , selectively weed the ... encourage the growth of their preferred algal species of ... Researchers writing in the open access journal BMC ... and explore their diverse gardening systems across the Indo-West ...
... circuits in newborn mice take around two weeks to become ... adds to understanding of the cold sensing protein TRPM8 (pronounced ... 2002 by David McKemy of the University of Southern California. ... the cold sensing circuit starts to develop in utero but ...
Cached Biology News:WHO guidelines on Buruli ulcer need adjustment 2When do newborns first feel cold? 2
...
... a-Amylase is an enzyme that ... mixture of maltose, maltotriose, and dextrins. ... of the human body is of,clinical ... states including,pancreatitis and diabetes; plant and ...
... series of Class II Biological Safety ... certification to the world's highest safety ... the cabinets cannot be adjusted out ... low noise and arm rest ensure ...
... Fluoroskan Ascent FL ... fluorometric and luminometric measurement ... long list of advanced ... and Luminoskan Ascent. Fluoroskan ...
Biology Products: